ONTOLOGY REPORT - ANNOTATIONS
| Term: | amphotericin B |
|
| Accession: | CHEBI:2682
|
browse the term
|
| Definition: | A macrolide antibiotic used to treat potentially life-threatening fungal infections. |
| Synonyms: | exact_synonym: | (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid |
| | related_synonym: | AMPH-B; Amphotericine B; C47H73NO17; InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1; InChIKey=APKFDSVGJQXUKY-INPOYWNPSA-N; Liposomal Amphotericin B; [H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\\C=C\\C=C\\C=C\\C=C\\C=C\\C=C\\C=C\\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2; amfotericina B; amphotericinum B |
| | alt_id: | CHEBI:106303; CHEBI:566395 |
| | xref_casrn: | 1397-89-3 |
| | xref: | Beilstein:4645978 "Beilstein Registry Number"; ChEMBL:106303 "ChEMBL COMPOUND"; ChEMBL:108873 "ChEMBL COMPOUND"; ChEMBL:1732516 "PubMed citation"; ChEMBL:17507115 "PubMed citation"; ChEMBL:566395 "ChEMBL COMPOUND"; ChemIDplus:1397-89-3 "CAS Registry Number"; DrugBank:1397-89-3 "CAS Registry Number"; DrugBank:DB00681 "DrugBank"; KEGG COMPOUND:1397-89-3 "CAS Registry Number"; KEGG COMPOUND:C06573 "KEGG COMPOUND"; KEGG DRUG:1397-89-3 "CAS Registry Number"; KEGG DRUG:D00203 "KEGG DRUG"; LIPID MAPS:LMPK06000002 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D000666 |
| | xref: | Patent:US2908611 "Patent"; Reaxys:4645978 "Reaxys Registry Number" |
|
|
amphotericin B
|
| G |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
|
increases expression |
ISO |
2 |
151,998,907 |
152,114,966 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Atg3 |
autophagy related 3 |
|
decreases expression |
ISO |
11 |
57,162,205 |
57,190,568 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
decreases expression |
EXP |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
affects expression |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
decreases expression |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
decreases expression |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Glod4 |
glyoxalase domain containing 4 |
|
decreases expression |
ISO |
10 |
63,575,440 |
63,600,076 |
RGD:6480464 |
CTD |
| G |
Gpr20 |
G protein-coupled receptor 20 |
|
increases expression |
ISO |
7 |
111,405,379 |
111,406,441 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
decreases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
decreases expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases activity |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1an |
hypoxia-inducible factor 1, alpha subunit inhibitor |
|
multiple interactions |
ISO |
1 |
249,607,945 |
249,618,000 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
increases expression |
ISO |
1 |
14,846,369 |
14,864,804 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Kcnq4 |
potassium voltage-gated channel, KQT-like subfamily, member 4 |
|
decreases expression |
ISO |
5 |
141,289,211 |
141,339,803 |
RGD:6480464 |
CTD |
| G |
Lsg1 |
large subunit GTPase 1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
11 |
72,026,815 |
72,051,401 |
RGD:6480464 |
CTD |
| G |
Nprl2 |
nitrogen permease regulator-like 2 (S. cerevisiae) |
|
decreases expression |
ISO |
8 |
112,789,664 |
112,792,837 |
RGD:6480464 |
CTD |
| G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
increases expression |
ISO |
1 |
252,204,106 |
252,329,479 |
RGD:6480464 |
CTD |
| G |
Paip1 |
poly(A) binding protein interacting protein 1 |
|
decreases expression |
ISO |
2 |
51,610,582 |
51,637,190 |
RGD:6480464 |
CTD |
| G |
Pard3 |
par-3 (partitioning defective 3) homolog (C. elegans) |
|
decreases expression |
ISO |
19 |
57,015,742 |
57,603,133 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
multiple interactions |
ISO |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Polm |
polymerase (DNA directed), mu |
|
increases expression |
ISO |
14 |
86,491,716 |
86,501,294 |
RGD:6480464 |
CTD |
| G |
Runx3 |
runt-related transcription factor 3 |
|
decreases expression |
ISO |
5 |
153,950,116 |
153,973,141 |
RGD:6480464 |
CTD |
| G |
Slit1 |
slit homolog 1 (Drosophila) |
|
decreases expression |
ISO |
1 |
246,813,909 |
246,964,408 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
affects expression |
EXP |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
affects expression |
EXP |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Usp36 |
ubiquitin specific peptidase 36 |
|
increases expression |
ISO |
10 |
108,264,874 |
108,296,384 |
RGD:6480464 |
CTD |
amphotericin B methyl ester
|
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
increases expression |
ISO |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
Term paths to the root
|